Piracetam produced a reduction of myoclonus

Antimyoclonic action of piracetam.

Obeso JA, Artieda J, Luquin MR, Vaamonde J, Martinez Lage JM.

Clin Neuropharmacol 1986;9(1):58-64

Abstract

Five patients with myoclonus were treated with oral piracetam (8-9 g/day). All patients had action-sensitive and/or stimulus-sensitive myoclonus and enhanced amplitude of somatosensory evoked potentials. Piracetam produced a marked reduction of the myoclonus in the five subjects without side effects. In view of its excellent tolerance and synergism with other anti-myoclonic drugs, we consider piracetam to be a very valuable drug for the treatment of patients with myoclonus of any origin.

Alzheimer's disease            www.AlzheimersTreatments.com

    piracetam and Alzheimer's

    piracetam therapy in Alzheimer's

    piracetam use in Alzheimer's

    piracetam induced changes in Alzheimer's

    piracetam effect on Alzheimer's

    piracetam reverses hippocampal changes in Alzheimer's

    piracetam and Alzheimer's disease

    piracetam controlled study on dementia

    piracetam effect on senile dementia memory

Alcoholism

    piracetam in acute alcohol withdrawal

    piracetam alcoholic treatment

    piracetam efficacy in chronic alcoholics

    piracetam effect on alcoholics

Child birth

    piracetam in parturients and newborn infants

    piracetam reduced duration of labor

    piracetam protective effect during delivery

    piracetam concentrations during delivery

Circulatory Disorders

    piracetam effectiveness in cerebral arteriosclerosis

    piracetam and chronic cerebrovascular disorders

    piracetam effect on brain circulation failure

Dyslexia

    piracetam learning aid in dyslexia

    piracetam in children with dyslexia

    piracetam in students with dyslexia

    piracetam efficacy in dyslexic reading and writing disorders

    piracetam verbal effect in dyslexic boys

    piracetam improves reading in dyslexia

Head injury

    piracetam and concussion

    piracetam effect on consciousness due to head injury

    piracetam protection in brain injury

    piracetam use in severe brain injury

Hearing loss

    piracetam use in sudden deafness

    piracetam sudden hearing loss treatment

    piracetam in tinnitus and sudden deafness

    piracetam treatment of sudden deafness

Heart Disease

    piracetam effects on arterial hypertension

    piracetam effect on elderly coronary heart disease

    piracetam in chronic ischemic heart disease

    piracetam in ischemic heart disease

    piracetam in myocardial infarct patients

Mental Performance

    piracetam improved mental performance

    piracetam and nootropics

    piracetam in patients with mental decline�

    piracetam effects on cognitive functions

    piracetam improves memory

    piracetam efficacy in cognitive impairment

    piracetam memory impairment trial

    piracetam and EEG of boys with learning disorders

    piracetam effect on adolescent brain function

    piracetam effects on human EEG

    piracetam on change in brain functional state

    piracetam effects on brain functions

    piracetam in elderly cerebral impairment

    piracetam in cerebral impairment

Stroke

    piracetam in secondary stroke prophylaxis

    piracetam improves blood flow of post-stroke patients

    piracetam improves aphasia in acute stroke

    piracetam in the treatment of acute stroke

    piracetam evaluation in acute stroke

    piracetam in stroke-unduced Aphasia

    piracetam treatment in ischemic stroke

    piracetam treatment of patients with an ischemic stroke

    piracetam acute stroke study

    piracetam effect on post-stroke recovery

    piracetam improvement in Stroke

    piracetam adjuvant to language therapy for aphasia

Vertigo

    piracetam treatment for vertigo

    piracetam is effective in vertigo

    piracetam effect in 55 vertigo patients

    piracetam subjective improvement in vertigo

    piracetam significantly reduced vertigo symptoms

Myoclonus

    piracetam and reduction of myoclonus

    piracetam relieves symptoms in myoclonus epilepsy

    piracetam in cortical myoclonus

    piracetam and progressive myoclonus epilepsy

    piracetam in patients with myoclonus

    piracetam in progressive myoclonus epilepsy

    piracetam promising results in myoclonus epilepsy

    piracetam long-term efficacy in myoclonus epilepsy

    piracetam beneficial use for severe myoclonus epilepsy

    piracetam beneficial effect on post-ischaemic myoclonus

Raynaud's

    piracetam treatment of Raynaud's

    piracetam evidence for its anti-platelet effect in Raynaud's

    piracetam platelet anti-aggregant properties

Sickle Cell disease

    piracetam treatment of children with sickle cell disease

    piracetam improves sickle cell deformability

    piracetam crises management of sickle cell disease

Misc.

    piracetam mechanism of action

    piracetam elevates cholinergic receptor density

    piracetam cholinergic receptor function in mice

    piracetam effects on schizophrenia

    piracetam effect on cerebral glucose utilization

    piracetam improved driving in elderly motorists

    piracetam unique mode of action

    piracetam study age-related memory disorders

    piracetam psychological treatment

    piracetam and aging

    piracetam and vigilance

    piracetam versus acetylcholinesterase inhibitors

    piracetam effects on arterial hypertension

    piracetam in cerebral palsy

    piracetam auxiliary treatment of cerebral palsy

    piracetam interaction in the motor cortex

    piracetam effect on consciousness after neurosurgery

    piracetam effect on cerebral infarction

    piracetam improves cognitive deficits in early Parkinsonism

    piracetam therapy in recurrent duodenal ulcer

    piracetam efficacy in recurrence of duodenal ulcer

    piracetam efficacy in breath-holding spells

    piracetam treatment of migraine

    piracetam treatment of soft tissue rheumatism�

    piracetam effect on intellectually deficient children

    piracetam effect on neuroleptic-induced side effects

    piracetam improved school-performance in legasthenia